United States · FDA National Drug Code directory
Atropine Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0641-6251_f5ca4281-8c89-4efc-80b1-2fbcf61c7c55
- Product NDC
- 0641-6251
- Form
- INJECTION
- Composition / generic term
- Atropine Sulfate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211201
- Source listing expiry
- 20261231
Source-listed ingredients
- ATROPINE SULFATE — .4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (0641-6251-10) / 20 mL in 1 VIAL · 0641-6251-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →